| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |